Pregnancy and Female Reproductive Disorders

  • Polly M Galbraith
Chapter

Abstract

Socioeconomic and cultural changes as well as medical advances continue to increase life expectancy and quality of life for women, especially those in their child-bearing years. Recent trends in the vital statistics of the USA and Europe document the decrease in the number of births, the birth rate, the age-adjusted death rate and the infant mortality rate. US life expectancy increased slightly to 75.7 in 1994, with women’s life expectancy an additional 3–7 years compared with men. Overall, age-adjusted death rates for women were lower for heart disease, malignancies, pulmonary disease, accidents and homicides.1 Mortality due to HIV, unfortunately, has continued to rise dramatically (see Chapter 36). US fertility rates for women aged 15–44 have declined to 67.1 live births per 1000 women. For all racial groups fertility has declined. Birth rates for teens appears to have leveled off. The number and proportion of women over age 30 giving birth continues to rise. A number of researchers have ascertained that the number of deaths due to pregnancy and its complications is underestimated in most developed countries.2 Despite this under-reporting phenomenon, pregnancy-related mortality is a relatively rare event.

Keywords

Gestational Diabetes Mellitus Ectopic Pregnancy Pelvic Inflammatory Disease Chronic Pelvic Pain Intrahepatic Cholestasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guyer B et al. Annual summary of vital statistics, 1994. Pediatrics 1995; 96(6): 1029–39.PubMedGoogle Scholar
  2. 2.
    Atrash HK, Alexander S, Berg CJ. Maternal mortality in developed countries: not just a concern of the past. Obstet Gynecol 1995; 86 (4Pt2): 700–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Martikained P. Women’s employment, marriage, motherhood and mortality: a test of the multiple role and role accumulation hypotheses. Soc Sci Med 1995; 40(2): 199–212.CrossRefGoogle Scholar
  4. 4.
    Mortality patterns—United States, 1993. MMWR Morb Mortal Wkly Rep 1996; 45(8): 161–4.Google Scholar
  5. 5.
    Samadi AR et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gyn ecol 1996 87(4): 557–63.CrossRefGoogle Scholar
  6. 6.
    Smith KE, Buyalos RP. The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril 1996; 65(1): 35–40.PubMedGoogle Scholar
  7. 7.
    Cooper LG, Leland NL, Alexander G. Effect of maternal age on birth outcomes among young adolescents. Soc Biol 1995; 42(1–2): 22–35.PubMedGoogle Scholar
  8. 8.
    Edwards LE et al. Pregnancy complications and birth outcomes in obese and normal weight women: effects of gestational weight change. Obstet Gynecol 1996; 87(3): 389–94.CrossRefPubMedGoogle Scholar
  9. 9.
    DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract 1995; 40(4): 385–94.PubMedGoogle Scholar
  10. 10.
    Ananth CV, Savitz DA, Bowes WA Jr. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1998–1991. Acta Obstet Gynecol Scand 1995; 74(10): 788–93.CrossRefPubMedGoogle Scholar
  11. 11.
    Ansari MZ, Müller BA, Krohn MA. Epidemiology of eclampsia. Eur J Epidemiol 1995; 11(4): 447–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Zamorski MA, Green LA. Preeclampsia and hypertensive disorders of pregnancy. Am Fam Physician 1996; 53(5): 1595–1610.PubMedGoogle Scholar
  13. 13.
    Nisell H et al. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995; 102 (11): 876–81.CrossRefPubMedGoogle Scholar
  14. 14.
    Damm P et al. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Diabetes Care 1995; 18(5): 654–65.CrossRefPubMedGoogle Scholar
  15. 15.
    Peters RK et al. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996; 347 (8996): 227–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Horton ES. NIDDM—the devastating disease. Diabetes Res Clin Pract 1995; 8(Suppll): S3–11.CrossRefGoogle Scholar
  17. 17.
    Hess W. Cardiovascular diseases during pregnancy. Anaesthetist 1995; 44(6): 395–404.CrossRefGoogle Scholar
  18. 18.
    Jordan E, Pugh LC. Pregnancy after cardiac transplantation. J Obstet Gynecol Neonatal Nurs 1996; 25(2): 131–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Knox TA, Olans LB. Liver disease in Pregnancy. N Engl J Med 1996; 335(8): 569–76.CrossRefPubMedGoogle Scholar
  20. 20.
    Lau WY et al. Hepatocellular carcinoma in pregnancy and its comparison with other pregnancy-associated malignancies. Cancer 1995; 75(11): 2669–76.CrossRefPubMedGoogle Scholar
  21. 21.
    Harrison RF et al. Course and outcome of IVF pregnancies. Eur J Obstet Gynecol Reprod Biol 1995; 59(2): 175–82.CrossRefPubMedGoogle Scholar
  22. 22.
    Tsai HD et al. A 12-year survey of 681 ectopic pregnancies. Obstet Gynecol 1995; 55(6): 457–62.Google Scholar
  23. 23.
    Talio CP et al. Maternal and neonatal morbidity with IVF. J Pediatr 1995; 127(5): 794–800.CrossRefGoogle Scholar
  24. 24.
    Kottman LM. Pelvic inflammatory disease: clinical overview. J Obstet Gynecol Neonatal Nurs 1995; 24(8): 759–67.CrossRefGoogle Scholar
  25. 25.
    Risch HA, Howe GR. Pelvic inflammatory disease and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1995; 4(5): 447–51.PubMedGoogle Scholar
  26. 26.
    Yusuf NW et al. Benign ovarian cysts—a retrospective evaluation over 2 years. JAMA 1995; 45 (3): 61–3.Google Scholar
  27. 27.
    Jacobs H, McKeigue P. In press. Personal communication.Google Scholar
  28. 28.
    Tay SK. Comparison of usefulness of serum CA 125 and risk of scoring system in detecting malignancy in ovarian cysts. Ann Acad Med 1995; 24(11): 168–71.Google Scholar
  29. 29.
    Kurman RJ et al. The behaviour of endometrial hyperplasia: a long term study of untreated hyperplasia in 170 patients. Cancer 1985; 56: 403–12.CrossRefPubMedGoogle Scholar
  30. 30.
    Santos-Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in Great Britain and relation to changing fertility and oral contraceptives. Br J Cancer 1995 72(2): 485–92.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Schlesselman JJ. Net effect of oral contraceptive use on cancer rise in women in United States. Obstet Gynecol 1995; 85(5ptl): 793–801.CrossRefPubMedGoogle Scholar
  32. 32.
    Grodstein F, Stampfer MJ. The epidemiology of coronary heart disease and estrogen replacement in post menopausal women. Prog Cardiovasc Dis 1995; 38: 199–210.CrossRefPubMedGoogle Scholar
  33. 33.
    The postmenopausal Estorgen/Progestin Interventions Trial Writing Group. Effects of estrogen or estrogen/progestin regimins on heart disease risk factors. JAMA 1995; 273: 199–208.CrossRefGoogle Scholar
  34. 34.
    Colditz GA et al. The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N Engl J Med 1995; 332: 1589–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Grodstein F et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61.CrossRefPubMedGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 2000

Authors and Affiliations

  • Polly M Galbraith

There are no affiliations available

Personalised recommendations